|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.20 EUR | -1.40% |
|
-0.35% | -6.93% |
| 23/04 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 06/04 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 49Cr 56Cr 45Cr 42Cr 79Cr 5.4TCr 81Cr 538.37Cr 208.44Cr 2.6TCr 211.8Cr 207.24Cr 9.05TCr | P/E Ratio 2024 |
41x | P/E Ratio 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 44Cr 51Cr 41Cr 38Cr 71Cr 4.87TCr 73Cr 485.75Cr 188.07Cr 2.35TCr 191.1Cr 186.98Cr 8.17TCr | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 day | -1.40% | ||
| 1 week | -0.35% | ||
| Current month | -0.70% | ||
| 1 month | +1.08% | ||
| 3 months | +7.43% | ||
| 6 months | -6.00% | ||
| Current year | -6.93% |
| 1 week | 28.1 | 28.9 | |
| 1 month | 26.1 | 29.5 | |
| Current year | 24.35 | 30.95 | |
| 1 year | 20.85 | 32.25 | |
| 3 years | 20.85 | 56.5 | |
| 5 years | 20.85 | 56.5 | |
| 10 years | 20.85 | 92.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 56 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/23/29 | Sell | 8,58,660 | 4.8939% | |||
| 29/23/29 | Sell | Director | 1,98,664 | 1.1323% | ||
| 29/23/29 | Sell | Director | 32,67,121 | 18.6209% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.40% | -0.35% | +22.34% | -26.18% | 56Cr | ||
| +0.82% | +4.01% | -11.30% | -3.81% | 1.33TCr | ||
| -1.10% | -2.21% | -35.37% | -56.82% | 491.86Cr | ||
| -0.22% | +2.94% | -9.20% | -2.82% | 474.29Cr | ||
| -1.86% | -5.35% | +8.38% | -21.79% | 377.8Cr | ||
| -1.61% | +0.40% | +2.70% | -43.28% | 375.53Cr | ||
| -2.69% | -4.14% | -5.21% | -10.76% | 358.7Cr | ||
| -0.91% | +1.00% | -13.63% | -5.90% | 313.09Cr | ||
| -1.50% | -2.43% | -13.60% | -32.08% | 225.37Cr | ||
| -6.14% | -3.41% | -15.13% | +24.40% | 171.63Cr | ||
| Average | -1.66% | -1.89% | -7.00% | -17.90% | 417.58Cr | |
| Weighted average by Cap. | -0.86% | -0.51% | -10.34% | -16.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 49Cr 56Cr 45Cr 42Cr 79Cr 5.38TCr 80Cr 536.11Cr 207.56Cr 2.59TCr 210.91Cr 206.37Cr 9.02TCr | 50Cr 58Cr 46Cr 43Cr 81Cr 5.53TCr 83Cr 551.01Cr 213.33Cr 2.67TCr 216.77Cr 212.1Cr 9.27TCr |
| Net income | 1.13Cr 1.31Cr 1.04Cr 97.91L 1.83Cr 125.08Cr 1.87Cr 12Cr 4.83Cr 60Cr 4.9Cr 4.8Cr 209.64Cr | 3.26Cr 3.76Cr 3.01Cr 2.82Cr 5.27Cr 360.18Cr 5.38Cr 36Cr 14Cr 173.62Cr 14Cr 14Cr 603.67Cr |
| Net Debt | -4.97Cr -5.73Cr -4.58Cr -4.3Cr -8.03Cr -548.8Cr -8.19Cr -55Cr -21Cr -264.54Cr -22Cr -21Cr -919.8Cr | -4.79Cr -5.51Cr -4.41Cr -4.13Cr -7.72Cr -528.02Cr -7.88Cr -53Cr -20Cr -254.52Cr -21Cr -20Cr -884.98Cr |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 28.20 € | -1.40% | 1,932 |
| 10/26/10 | 28.60 € | -0.35% | 1,911 |
| 09/26/09 | 28.70 € | +1.06% | 1,734 |
| 08/26/08 | 28.40 € | -1.39% | 1,981 |
| 05/26/05 | 28.80 € | +1.77% | 3,521 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
















